KUALA LUMPUR: PMCK Bhd
said it is taking a prudent and selective approach to growth, prioritising expansion opportunities that offer clear strategic fit and financial merit.
“In terms of our growth strategy, we are prudently assessing selective merger and acquisition opportunities to complement our existing operations, with any potential transactions to be pursued only where there is clear strategic alignment and financial merit,” managing director Datuk Lee Gaik Cheng said in a statement.
The private healthcare services provider posted a net profit of RM5.76 mil, or earnings per share of 0.53 sen, in the second quarter ended Oct 31, 2025 (2Q26), supported by stronger inpatient volumes, improved cost efficiency and a net gain from the settlement related to undelivered Covid-19 vaccines.
Revenue for the quarter stood at RM25.42mil, driven mainly by higher inpatient admissions and improved bed occupancy rates.
PMCK said inpatient care remained the group’s primary revenue contributor, accounting for about 79.15% of total revenue, while healthcare support services contributed approximately 70.74%.
For the six months ended Oct 31, PMCK reported revenue of RM47.18mil and net profit of RM6.60mil, with earnings per share of RM0.62.
As at Oct 31, PMCK’s total assets expanded to RM196.08mil, compared with RM122.69mil as at April 30, following its initial public offering (IPO).
Its shareholders’ equity strengthened to RM155.07mil, up from RM90.52mil previously, while net assets per share improved to RM0.14 from RM0.11.
PMCK also maintained a solid cash and investments position of RM93.05mil.
The board declared a first interim dividend of 0.12 sen per share, amounting to RM1.31mil, for the financial year ending April 30, 2026, payable on Jan 28, 2026, with an entitlement date of Jan 9, 2026.
“We are encouraged by the group’s second-quarter performance, which was underpinned by higher inpatient volumes, better bed occupancy and a more normalised cost structure following our listing.
“The contribution from the Hospital Services Outsourcing Programme (HSOP) also provided additional support during the quarter,” Lee said.
Looking ahead, she said PMCK remains cautiously optimistic on its near-term outlook, supported by steady demand for private healthcare services and ongoing public–private collaboration within Malaysia’s healthcare sector.
“While the HSOP is scheduled to conclude in December 2025, we expect patient volumes, to remain resilient in the coming quarters, subject to operational conditions,” Lee said.
